Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mayne Pharma Group (DE:HG6)
FRANKFURT:HG6
Mayne Pharma Group (HG6) Ownership - Who Owns Mayne Pharma Group?
0 Followers
Mayne Pharma Group (HG6) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
The ownership structure of Mayne Pharma Group (DE:HG6) stock is a mix of institutional, retail and individual investors. Approximately <0.01% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 100.00% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 05, 2023 | Frank Charles Condella Chairman,director | Bought | AU$38811 |
| Oct 27, 2023 | Shawn Patrick O’brien Chief Executive Officer & Managing Director | Bought | AU$140919 |
| Oct 25, 2023 | Kathryn Macfarlane Non Executive,director | Bought | AU$69120 |
| Oct 23, 2023 | Ann Custin Non Executive,director | Bought | AU$41128 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 38,000 | Insider | ― | 162,640 | |
| 634,895 | Insider | ― | 2,717,351 | |
| 6,739,554 | Insider | ― | 28,845,291 | |
| 25,604,210 | Insider | ― | 109,586,019 | |
| 3,280,000 | Insider | ― | 14,038,400 | |
| 20,000 | Insider | ― | 85,600 | |
| 22,097 | Insider | ― | 94,575 | |
| 1,587,217 | Insider | ― | 6,793,289 | |
| 105,577,583 | Insider | ― | 451,872,055 | |
| 2,158,636 | Insider | ― | 9,238,962 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,925 | Institution | ― | 40,912 | |
| 1,969 | Institution | ― | 9,026 | |
| 455,075 | Institution | ― | 2,086,064 | |
| 19,079 | Institution | ― | 87,458 | |
| 23,804 | Institution | ― | 109,118 | |
| 1,120 | Institution | ― | 5,134 | |
| 4,957 | Institution | ― | 22,723 | |
| 657,999 | Institution | ― | 3,016,267 | |
| 432,015 | Institution | ― | 1,980,357 | |
| 1,079,628 | Institution | ― | 4,949,015 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Mayne Pharma Group (DE:HG6)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 100.00% is held by retail investors.
What percentage of Mayne Pharma Group (DE:HG6) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Mayne Pharma Group (DE:HG6) stock is held by institutional investors.
What percentage of Mayne Pharma Group (DE:HG6) stock is held by retail investors?
According to the latest TipRanks data, approximately 100.00% of Mayne Pharma Group (DE:HG6) stock is held by retail investors.
Who owns the most shares of Mayne Pharma Group (DE:HG6)?
Kathryn Macfarlane owns the most shares of Mayne Pharma Group (DE:HG6).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.